Phosphene perceptions and safety of chronic visual cortex stimulation in a blind subject.

blind diagnostic technique electrical stimulation phosphene visual cortex visual perception visual prosthesis

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
31 May 2019
Historique:
received: 26 09 2018
accepted: 04 03 2019
pubmed: 1 6 2019
medline: 1 6 2019
entrez: 1 6 2019
Statut: epublish

Résumé

Stimulation of primary visual cortices has the potential to restore some degree of vision to blind individuals. Developing safe and reliable visual cortical prostheses requires assessment of the long-term stability, feasibility, and safety of generating stimulation-evoked perceptions.A NeuroPace responsive neurostimulation system was implanted in a blind individual with an 8-year history of bare light perception, and stimulation-evoked phosphenes were evaluated over 19 months (41 test sessions). Electrical stimulation was delivered via two four-contact subdural electrode strips implanted over the right medial occipital cortex. Current and charge thresholds for eliciting visual perception (phosphenes) were measured, as were the shape, size, location, and intensity of the phosphenes. Adverse events were also assessed.Stimulation of all contacts resulted in phosphene perception. Phosphenes appeared completely or partially in the left hemifield. Stimulation of the electrodes below the calcarine sulcus elicited phosphenes in the superior hemifield and vice versa. Changing the stimulation parameters of frequency, pulse width, and burst duration affected current thresholds for eliciting phosphenes, and increasing the amplitude or frequency of stimulation resulted in brighter perceptions. While stimulation thresholds decreased between an average of 5% and 12% after 19 months, spatial mapping of phosphenes remained consistent over time. Although no serious adverse events were observed, the subject experienced mild headaches and dizziness in three instances, symptoms that did not persist for more than a few hours and for which no clinical intervention was required.Using an off-the-shelf neurostimulator, the authors were able to reliably generate phosphenes in different areas of the visual field over 19 months with no serious adverse events, providing preliminary proof of feasibility and safety to proceed with visual epicortical prosthetic clinical trials. Moreover, they systematically explored the relationship between stimulation parameters and phosphene thresholds and discovered the direct relation of perception thresholds based on primary visual cortex (V1) neuronal population excitation thresholds.

Identifiants

pubmed: 31151104
doi: 10.3171/2019.3.JNS182774
pii: 2019.3.JNS182774
doi:
pii:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2000-2007

Auteurs

Soroush Niketeghad (S)

1Department of Bioengineering, University of California, Los Angeles.

Abirami Muralidharan (A)

2Second Sight Medical Products Inc., Sylmar, California.

Uday Patel (U)

2Second Sight Medical Products Inc., Sylmar, California.

Jessy D Dorn (JD)

2Second Sight Medical Products Inc., Sylmar, California.

Laura Bonelli (L)

Departments of3Ophthalmology and.

Robert J Greenberg (RJ)

2Second Sight Medical Products Inc., Sylmar, California.

Nader Pouratian (N)

1Department of Bioengineering, University of California, Los Angeles.
4Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles; and.

Classifications MeSH